Literature DB >> 15474499

PPAR-gamma overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein.

Eisuke Ito1, Sachihiko Ozawa, Kazuto Takahashi, Toshiaki Tanaka, Hidenori Katsuta, Shinya Yamaguchi, Masahiro Maruyama, Makoto Takizawa, Hiroshi Katahira, Katsuhiko Yoshimoto, Shinya Nagamatsu, Hitoshi Ishida.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) regulates several cellular functions, but its physiological role in pancreatic islet cells remains to be investigated. In this study, we confirmed the presence of PPAR-gamma in rat isolated islets and examined its role on insulin and glucagon secretion by using PPAR-gamma-overexpressed islets. PPAR-gamma overexpression significantly suppressed insulin secretion induced by stimulatory concentration of glucose (p<0.05). In addition, insulin secretion evoked by high potassium depolarization also was significantly decreased from PPAR-gamma-overexpressed islets (p<0.05). On the other hand, no significant change in glucagon release was observed after high potassium depolarization between PPAR-gamma-overexpressed and control islets. Insulin and glucagon content in islets was not statistically different between the two groups. In addition, the expression of uncoupling protein-2 (UCP-2) was found to be induced in PPAR-gamma-overexpressed islets. This result clearly indicates that the deteriorative effect of PPAR-gamma overexpression on the secretory machinery is selective for pancreatic beta-cells. And it is possible that its site of action can be located in the energy-consuming exocytotic process of insulin secretory granules, and that the reduction of ATP production through increased UCP-2 reduces insulin exocytosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474499     DOI: 10.1016/j.bbrc.2004.08.238

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Uncoupling proteins: role in insulin resistance and insulin insufficiency.

Authors:  Catherine B Chan; Mary-Ellen Harper
Journal:  Curr Diabetes Rev       Date:  2006-08

2.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

3.  Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species.

Authors:  N Produit-Zengaffinen; N Davis-Lameloise; H Perreten; D Bécard; A Gjinovci; P A Keller; C B Wollheim; P Herrera; P Muzzin; F Assimacopoulos-Jeannet
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

4.  RNA-Seq Analysis of Islets to Characterise the Dedifferentiation in Type 2 Diabetes Model Mice db/db.

Authors:  Abraham Neelankal John; Ramesh Ram; Fang-Xu Jiang
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

Review 5.  Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion.

Authors:  Shafat Ali; Shazia Nafis; Ponnusamy Kalaiarasan; Ekta Rai; Swarkar Sharma; Rameshwar N Bamezai
Journal:  Rev Diabet Stud       Date:  2016-05-10

6.  Mitochondrial Ca2+, the secret behind the function of uncoupling proteins 2 and 3?

Authors:  Wolfgang F Graier; Michael Trenker; Roland Malli
Journal:  Cell Calcium       Date:  2008-02-20       Impact factor: 6.817

Review 7.  Role of ZAC1 in transient neonatal diabetes mellitus and glucose metabolism.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  World J Biol Chem       Date:  2015-08-26

8.  Fatty acids do not activate UCP2 in pancreatic beta cells: comparison with UCP1.

Authors:  Sandrine Galetti; Alexandre Sarre; Hélène Perreten; Nathalie Produit-Zengaffinen; Patrick Muzzin; Françoise Assimacopoulos-Jeannet
Journal:  Pflugers Arch       Date:  2008-07-15       Impact factor: 3.657

9.  Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.

Authors:  Min Yang; Qiong Huang; Jing Wu; Ji-Ye Yin; Hong Sun; Hai-Ling Liu; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

10.  BCL-6: a possible missing link for anti-inflammatory PPAR-delta signalling in pancreatic beta cells.

Authors:  I Kharroubi; C-H Lee; P Hekerman; M I Darville; R M Evans; D L Eizirik; M Cnop
Journal:  Diabetologia       Date:  2006-08-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.